Article

Visionary 'Dr. V' changed eye care in India

With the passing of Govindappa Venkataswamy, MD, 87, founder and chairman of the Aravind Eye Care System in Madurai, India, on July 7, the worldwide ophthalmology community lost a visionary and inspirational leader.

With the passing of Govindappa Venkataswamy, MD, 87, founder and chairman of the Aravind Eye Care System in Madurai, India, on July 7, the worldwide ophthalmology community lost a visionary and inspirational leader.

Designed to be self-sustaining while providing high-quality care to an underserved population, the fledgling hospital relied on fees paid by about 30% of patients to subsidize free care for the remainder, plus a formula based on low costs and high volume.

Universal eye care

"One of the key things that he did was to make eye care available to all, and he made it available in a way that was more giving," said Aravind Srinivasan, MD, an ophthalmologist, executive in the Aravind system, and nephew of Dr. Venkataswamy.

"He came up with the vision of eradicating needless blindness, and the realization was that he alone could not do this, that the Aravind hospital alone could not do it, and that we would have to facilitate training for other surgeons and other staff members, such as nurses, technicians, administrators, and managers. So he started training programs," Dr. Srinivasan said.

"The direct impact is huge, and the indirect impact is compounding," Dr. Srinivasan said. "Aravind is more like a platform where people come to innovate, learn, and share.

"We are learning from others and sharing with others," he added. "That's how we look at Aravind-not so much as one organization trying to eradicate needless blindness. That's not what Dr. V wanted us to do."

The success of Dr. Venkataswamy's vision is evident by the fact that Tamil Nadu now has a rate of eye disease 20% less than that of India as a whole, while the incidence in that region was considerably higher than the nationwide rate when the eye-care program began, according to his nephew.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.